Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Auto-Enrollment Of Dual-Eligibles Should Precede Medicare Drug Benefit – PhRMA

This article was originally published in The Pink Sheet Daily

Executive Summary

Pre-emptive assigning of dual-eligibles to Medicare drug plans once the enrollment period commences may be necessary to avoid lapses in their drug coverage, the trade association advises CMS. AHIP and BIO echo PhRMA's concerns.

You may also be interested in...



All Dual-Eligibles Will Be Enrolled In Medicare Part D By Start Date, McClellan Says

The agency will employ auto-enrollment for beneficiaries eligible for Medicare and Medicaid by Jan. 1, 2006 to avoid potential coverage gaps, CMS Administrator McClellan says. The Medicare Today coalition kicks-off national public education campaign on Medicare Rx.

All Dual-Eligibles Will Be Enrolled In Medicare Part D By Start Date, McClellan Says

The agency will employ auto-enrollment for beneficiaries eligible for Medicare and Medicaid by Jan. 1, 2006 to avoid potential coverage gaps, CMS Administrator McClellan says. The Medicare Today coalition kicks-off national public education campaign on Medicare Rx.

CMS Will Auto-Enroll 1.8 Mil. Low-Income Seniors For Medicare Rx Cards

The agency will randomly assign all Medicare Savings Program beneficiaries into one of 19 participating national cards. The addition of 1.8 mil. beneficiaries brings the total number of card program enrollees up 41% to 6.2 mil.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel